Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Reynolds

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nurse Educator|May 5, 2009
Lights... camera... action! a guide for creating a DVD/videoSusan E Fleming, Jerry Reynolds, Barb Wallace
Frontiers in Neurology|April 30, 2021
Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1Leigh Hartog, Jing Zhao, Jerry Reynolds, et al.
Frontiers in Neurology|May 3, 2021
Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular AtrophyBakri Elsheikh, Steven Severyn, Songzhu Zhao, et al.
Frontiers in Neurology|June 7, 2021
Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMABakri Elsheikh, Steven Severyn, Songzhu Zhao, et al.
BMJ Neurology Open|September 1, 2021
Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersenW David Arnold, Steven Severyn, Songzhu Zhao, et al.
Journal of Neuromuscular Diseases|November 15, 2021
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with NusinersenKelly A Rich, Ashley Fox, Mehmet Yalvac, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nurse Educator|May 5, 2009
Lights... camera... action! a guide for creating a DVD/videoSusan E Fleming, Jerry Reynolds, Barb Wallace
Frontiers in Neurology|April 30, 2021
Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1Leigh Hartog, Jing Zhao, Jerry Reynolds, et al.
Frontiers in Neurology|May 3, 2021
Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular AtrophyBakri Elsheikh, Steven Severyn, Songzhu Zhao, et al.
Frontiers in Neurology|June 7, 2021
Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMABakri Elsheikh, Steven Severyn, Songzhu Zhao, et al.
BMJ Neurology Open|September 1, 2021
Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersenW David Arnold, Steven Severyn, Songzhu Zhao, et al.
Journal of Neuromuscular Diseases|November 15, 2021
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with NusinersenKelly A Rich, Ashley Fox, Mehmet Yalvac, et al.
Pageof 1